FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Breakthrough Status for SeQuent Please Balloon Catheter

[ Price : $8.95]

FDA grants B. Braun Interventional Systems a breakthrough device designation for the SeQuent Please ReX drug-coated percutaneous t...

FDA, EMA Early Access Approach Report

[ Price : $8.95]

FDA and the European Medicines Agency publish the report on a 2018 joint workshop on quality development in drug early access appr...

Info Collection Extension for Device GMPs

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension for medical device GMP regulation.

Info Collection Extension for UDI System

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension for Unique Device Identification (UDI) System ...

Neonatal Study Considerations Guidance

[ Price : $8.95]

FDA publishes a draft guidance to assist drug sponsors planning to conduct clinical studies in neonates.

ICH Clinical Studies Draft Guide Released

[ Price : $8.95]

FDA makes available a draft guidance entitled E8(R1) General Considerations for Clinical Studies.

FDA, HHS Drug Importation Plan Out

[ Price : $8.95]

FDA and HHS issue a plan with two potential paths for importing certain drugs from foreign countries, but Canadians object.

Cipla Virgonagar FDA-483 Released

[ Price : $8.95]

FDA releases the FDA-483 with seven inspection observations issued following an agency inspection at the Cipla Virgonagar, India, ...

FDA OKs Bayers Nubeqa for Prostate Cancer

[ Price : $8.95]

FDA approves a Bayer NDA for Nubeqa (darolutamide), an androgen receptor inhibitor for treating patients with non-metastatic castr...

HDE Info Collection Extension Sent to OMB

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension for Information that should be included with Humanit...